SQZ Biotech slashes headcount by 60% as founder/CEO hits exit — while Synlogic lays off 25%
It’s a tough time for early-stage companies developing highly promising, but largely unproven, new technologies.
Just ask SQZ Biotechnologies and Synlogic. The former is bidding …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
